Evaluating the cost-effectiveness of COVID-19 mRNA primary-series vaccination in Qatar: An integrated epidemiological and economic analysis.
Saved in:
| Title: | Evaluating the cost-effectiveness of COVID-19 mRNA primary-series vaccination in Qatar: An integrated epidemiological and economic analysis. |
|---|---|
| Authors: | Chemaitelly H; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.; Department of Health Policy, London School of Economics, London, United Kingdom.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, United States of America., Ayoub HH; Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar., Coyle P; Hamad Medical Corporation, Doha, Qatar.; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, United Kingdom., Tang P; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada., Hasan MR; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada., Yassine HM; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar., Al Thani AA; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar., Al-Kanaani Z; Hamad Medical Corporation, Doha, Qatar., Al-Kuwari E; Hamad Medical Corporation, Doha, Qatar., Jeremijenko A; Hamad Medical Corporation, Doha, Qatar., Kaleeckal AH; Hamad Medical Corporation, Doha, Qatar., Latif AN; Hamad Medical Corporation, Doha, Qatar., Shaik RM; Hamad Medical Corporation, Doha, Qatar., Abdul-Rahim HF; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar., Nasrallah GK; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar., Al-Kuwari MG; Primary Health Care Corporation, Doha, Qatar.; College of Medicine, Qatar University, Doha, Qatar., Butt AA; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, United States of America.; Hamad Medical Corporation, Doha, Qatar.; Department of Medicine, Weill Cornell Medicine, Cornell University, New York, New York, United States of America., Al-Romaihi HE; Ministry of Public Health, Doha, Qatar., Al-Thani MH; Ministry of Public Health, Doha, Qatar., Al-Khal A; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, United Kingdom., Bertollini R; Ministry of Public Health, Doha, Qatar., Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, United States of America.; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; College of Health and Life Sciences, Hamad bin Khalifa University, Doha, Qatar. |
| Source: | PloS one [PLoS One] 2025 Sep 26; Vol. 20 (9), pp. e0331654. Date of Electronic Publication: 2025 Sep 26 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0331654 |
